학술논문
Use of canakinumab and remdesivir in moderate-severe COVID-19 patients: A retrospective analysis.
Document Type
Article
Author
Source
International Journal of Immunopathology & Pharmacology; 8/3/2023, p1-8, 8p
Subject
Language
ISSN
03946320